• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Sunshine Biopharma Inc. - Common stock (NQ:SBFM)

    1.100 UNCHANGED
    Streaming Delayed Price Updated: 3:56 PM EDT, May 4, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 0
    Open 1.100
    Bid (Size) 0.9500 (200)
    Ask (Size) 1.530 (5,800)
    Prev. Close 1.100
    Today's Range 1.100 - 1.100
    52wk Range 0.9500 - 2.430
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Sunshine Biopharma Reports Fiscal 2025 Revenue of $36.3 Million, a 4.1% Increase Over Prior Year
    Via ACCESS Newswire
    News headline image
    Sunshine Biopharma Scores a Major Regulatory Win to Market Domperidone in Canada (NASDAQ: SBFM)
    Via ACCESS Newswire

    Performance

    YTD
    -14.1%
    -14.1%
    1 Month
    +5.8%
    +5.8%
    3 Month
    -10.6%
    -10.6%
    6 Month
    -35.7%
    -35.7%
    1 Year
    -19.7%
    -19.7%

    More News

    Read More
    News headline image
    Sunshine Biopharma Gains FDA-Equivalent Clearance in Canada for Domperidone to Treat Cancer-related Nausea
    Via ACCESS Newswire
    News headline image
    Sunshine Biopharma Launches STD, Acne and Lyme Disease Therapy Doxycycline
    Via ACCESS Newswire
    Sunshine Biopharma Stock Powers Ahead Following Launch Of Generic Cholesterol-Lowering Drug By Canadian Unit ↗
    Via Stocktwits
    News headline image
    Sunshine Biopharma Stock Is Surging Thursday: Here's What's Happening ↗
    Via Benzinga
    News headline image
    12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
    Via Benzinga
    News headline image
    Sunshine Biopharma Launches Cholesterol Fighting Medicine Pravastatin
    Via ACCESS Newswire
    News headline image
    Sunshine Biopharma Stock is 34% Higher Since September as Investors Reward Performance Combined with Innovation (NASDAQ: SBFM)
    Via AB Newswire
    News headline image
    Sunshine Biopharma is Proving That Riding Momentum is an Effective Strategy (NASDAQ:SBFM)
    Via ACCESS Newswire
    News headline image
    Sunshine Biopharma Proves Microcap Ambition Can Deliver Large-Cap Level Execution (NASDAQ: SBFM)
    Via ACCESS Newswire
    News headline image
    Sunshine Biopharma Allocates $5 Million for Investment in Bitcoin as Strategic Reserve Asset to Enhance Treasury Resilience
    Via ACCESS Newswire
    News headline image
    Sunshine Biopharma and University of Arizona Develop a Potent New Series of Protease Inhibitors for Treatment of SARS Coronavirus Infections
    Via ACCESS Newswire
    News headline image
    12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
    Via Benzinga
    News headline image
    Sunshine Biopharma Stock Soars After Launch Of First Biosimilar In $10B Canadian Market: Retail Bulls Charge In ↗
    Via Stocktwits
    News headline image
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
    Via Benzinga
    News headline image
    Sunshine Biopharma Launches NIOPEG(R) Into $10 Billion Biologics Market
    Via ACCESS Newswire
    News headline image
    Sunshine Biopharma Unit Launches Generic Anticonvulsant In Canada: Retail Sees ‘Huge Potential’ ↗
    Via Stocktwits
    News headline image
    Sunshine Biopharma Launches Generic Gabapentin for Neuropathic Pain in the Canadian Segment of the Global $1.92 Billion Market
    Via ACCESS Newswire
    News headline image
    Sunshine Biopharma Reports 2025 First Quarter Results, Revenues Up 18% Over Same Period Last Year
    Via ACCESS Newswire
    News headline image
    Sunshine Biopharma Launches Generic Lurasidone for Schizophrenia in the Canadian Sector of the Global $1.2 Billion Market
    Via ACCESS Newswire
    News headline image
    Sunshine Biopharma Boosts Retail Trader Appeal After Canadian Launch Of Generic Cancer Drug ↗
    Via Stocktwits
    News headline image
    The market is filled with gapping stocks in Monday's session. ↗
    Via Chartmill
    News headline image
    What's going on in today's pre-market session ↗
    Via Chartmill
    News headline image
    Sunshine Biopharma Launches Everolimus In Canada, an Oncology Drug with an Estimated Global Market of $2.5 Billion
    Via ACCESS Newswire

    Frequently Asked Questions

    Is Sunshine Biopharma Inc. - Common stock publicly traded?
    Yes, Sunshine Biopharma Inc. - Common stock is publicly traded.
    What exchange does Sunshine Biopharma Inc. - Common stock trade on?
    Sunshine Biopharma Inc. - Common stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Sunshine Biopharma Inc. - Common stock?
    The ticker symbol for Sunshine Biopharma Inc. - Common stock is SBFM on the Nasdaq Stock Market
    What is the current price of Sunshine Biopharma Inc. - Common stock?
    The current price of Sunshine Biopharma Inc. - Common stock is 1.100
    When was Sunshine Biopharma Inc. - Common stock last traded?
    The last trade of Sunshine Biopharma Inc. - Common stock was at 05/04/26 03:56 PM ET
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.